| Title: | Associate Professor |
| Dept: | Chemistry |
| Office: | SI 313 |
| Phone: | 216-687-3919 |
| Fax: | 216-687-9289 |
| Email: | X.SUN55@csuohio.edu |
| Web: | http://academic.csuohio.edu/sunlab |
| Address: | 2121 Euclid Ave. SI 313, Cleveland, OH 44115 |
Education: | ||
|
B.S., Pharmaceutics, Shenyang Pharmaceutical University, Sheyang, China, 1988
M.S., Pharmaceutical Chemistry, Kitasato University, Tokyo, Japan, 1994 Ph.D., Pharmaceutical Chemistry, Kitasato University, Tokyo, Japan, 1997 | ||
| Brief Bio: | ||
| After trained in pharmaceutical sciences, Dr. Sun has experienced a wide range of pharmaceutical and biomedical researches. First, he had worked on anti-influenza agent (Medicinal Chemistry) at RIKEN Institute (Japan) as a basic science special research fellow working with Dr.s Chi-Huey Wong, Osamu Kanie and Yukishige Ito, then worked on antithrombotic biomaterials (Biomedical Engineering) at Emory University School of Medicine as a NIH-funded research fellow working with Dr. Elliot L. Chaikof, Since 2002, Dr. Sun has started his academic career at Emory University School of Medicine first and Cleveland State University now as an associate professor working on Bioanalytical and Pharmaceutical and Medicinal Chemistry research. | ||
| Honors and Awards: | ||
| 2009 Invited Guest Editor of a Special Issue on Carbohydrate Recognition for Medicinal Research Reviews (peer reviewed journal, Wiley InterScience), to be published by the end of 2009
2009 Co-Chair of Organic Chemistry Session of CERMACS2009 (Central Regional Meeting of American Chemical Society), May 20-23, 2009, Cleveland, Ohio 2008- Editorial Board, Virus Adaptation and Treatment (peer reviewed journal, Dove Medical Press) 2008 Elected Host/Organizer of 4th Midwest Carbohydrate and Glycobiology Symposium, October 3-4, 2008, Cleveland, Ohio 2008 Featured on the cover page of Bioconjugate Chemistry (2008, Volume 19, Issue 1, American Chemical Society) 2007, 2008, 2009- Peer Review Committee Member of Grant Proposal, Bioengineering and Biotechnology Study Group-3, American Heart Association (National) 2007 Most-Cited Articles No.1 in 2006 full year in Bioconjugate Chemistry (American Chemical Society) 2007 Most-Accessed Articles No. 3 in 2006 full year in Bioconjugate Chemistry (American Chemical Society) 2007 Cleveland State University Faculty Research Development Program Award 2007-2006 Complimentary Membership of ASM International Material Information Society 2006-2004 Guest Professor of ShenYang Pharmaceutical University, China 2005-2004 Emory University Research Committee Award. | ||
| Research Interests: | ||
| The main research interests in Dr. Sun' group are in the following three areas:
1. Functional glyco-affinity ligand engineering: For proteomics and glycomics, pathogen and biomarker identification, antiviral drug and targeted drug delivery applications. 2. Cytomimetic antithrombotics: To explore vascular pathological and surgical interventional sites-local/targeted antithrombotics. 3. Biological and cellular chemistry: To develop site-specific/chemo- and bio-orthogonal and live cell compatible approaches for biomolecules, biomaterials and cells modification and functionalization. | ||
| Teaching Areas: | ||
| Organic Chemistry
Medicinal Chemistry Pharmacology | ||
| Professional Affiliations: | ||
| American Chemical Society
American Association of Pharmaceutical Scientists The Society of Glycobiology American Heart Association | ||
| Professional Experience: | ||
| 2009- Cleveland State University, Associate Professor, Department of Chemistry, Cleveland, OH
2007- Cleveland Clinic, Adjunct Staff, Department of Molecular Cardiology, the Lerner Research Institute, Cleveland, OH. 2006-2009 Cleveland State University, Assistant Professor, Department of Chemistry, Cleveland, OH 2002-2006 Emory University School of Medicine, Assistant Professor, Department of Surgery and Biomedical Engineering, Atlanta, GA. 2002-2000 Emory University School of Medicine, NIH-Funded Research Fellow, Department of Surgery, Atlanta, GA. 2000-1997 RIKEN (The Institute of Physical and Chemical Research), Basic Sciences Special Research Fellow, Laboratory of Glycotechnology & Synthetic Cellular Chemistry Laboratory, Saitama, Japan. 1991-1989 ShenYang Pharmaceutical University, Research Assistant, Department of Medicinal and Natural Product Chemistry, ShenYang, China. | ||
| Professional Service: | ||
| Editorial Board
Virus Adaptation and Treatment (Dove Medical Press) Invited Peer Review Committee: Peer Review Committee Member (2007, 2008, 2009), Bioengineering and Biotechnology Study Group, American Heart Association (National). Invited Manuscripts Reviewer for Journals: Nature Protocol, Organic Letters, ChemBioChem, A European Journal of Chemical Biology, Bioconjugate Chemistry, Bioorganic Medicinal Chemistry, Bioorganic Medicinal Chemistry Letter, Biomacromolecules, Molecular Diversity, Food and Chemical Toxicology, Acta Biomaterialia, Macromolecular Chemistry & Physics, Carbohydrate Polymers, Journal of Biomedical Material Research, Macromolecular Biosience, European Polymer Journal. Invited Book and Article Reviewer for Journals: ChemMedChem (European Jorunal of Medicinal Chemistry, Wiley Interscience). Pharmacia (Journal of the Pharmaceutical Society of Japan) Invited Book Proposal Reviewer: ACS Symposium Series Book: Chemical Glycobiology I: Glycoconjugates and Carbohydrate-Protein Interaction, Editors: Xin Chen, Randall Halcomb and Peng George Wang, 2006 Invited Database Reviewer: ASMs Materials for Medical Device Database, ASM International, The materials Information Society, 2006 | ||
| Research Grants: | ||
| Active:
Title: Thrombogenic Site-Directed Antithrombotics Role: Principle Investigator Agency: American Health Assistance Foundation Period: 04/01/2007-3/31/2010 Title: Antithrombogenic Membrane-Mimetic Assemblies Role: Co-Investigator (PI: E. Chaikof) Agency: National Institute of Health Type: 2RO1HL056819-09A1 Period: 08/15/2006-06/30/2011 Completed: Title: Universal Capture Array for the Discovery of Biomarker of Atherosclerosis Role: Principle Investigator Agency: Cleveland State University Faculty Research Development Program Period: 07/01/2007-6/30/2009 Title: Site-Targeted Liposomal Antithrombotic and Antiinflammatory Agent Role: Principle Investigator Agency: American Heart Association Type: Beginning-in-Aid, 0565287B Period: 07/01/2005-8/30/2006 Title: Antithrombogenic Membrane-Mimetic Assemblies Role: Co-Investigator (PI: E. Chaikof) Agency: National Institute of Health Type: 5RO1HL056819-08 Period: 09/01/2002-12/31/2005 Title: Site-Specific Antithrombotic Role: Principle Investigator Agency: Emory University Research Committee Type: URC-A2003107 Period: 01/01/2004-12/31/2004 | ||